| HOME >> BIOLOGY >> TECHNOLOGY |
About ChanTest - The Ion Channel/GPCR Company (www.chantest.com)
The leading experts in ion channels and GPCRs (G-protein coupled receptors), ChanTest helps its global pharmaceutical and biotech customers speed the drug-discovery and development process, save time and money, and ultimately make better, safer drugs. ChanTest offers ion channel and GPCR services (both automated high-throughput and GLP), cell lines, differentiated human stem cells, membranes, and related products that cover nearly half of the known drugable genome, along with cell line construction and scale-up, membrane preparation, and large-scale cryopreservation of cells for high-throughput screening. Since its inception in 1998, ChanTest has tested more than 20,000 compounds for more than 500 pharmaceutical and biotech companies worldwide. ChanTest continues to expand its cell line library with funding from the Ohio Department of Development's Third Frontier Program. Now, for the first time, customers can profile the efficacy and selectivity of drug leads against an extensive set of ion channels and GPCRs in functional, cell-based assays. ChanTest can screen drug leads, or large compound collections, against its entire catalog, against specific therapeutic/safety target ChanTest Panels(TM), or against customers' custom-designed panels. ChanTest is based in Cleveland, Ohio. For more information, e-mail info@chantest.com.
About Ohio Third Front
'/>"/>
| SOURCE ChanTest Copyright©2009 PR Newswire. All rights reserved |